Cash Flow BioMarin Pharmaceutical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
541.00
188.00
149.00
-75.00
-42.00
-94.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-216.00
-336.00
-96.00
66.00
-224.00
-101.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
572.00
159.00
175.00
304.00
85.00
48.00
Cash Flow from Investing Activities
136.00
-111.00
-20.00
-366.00
-53.00
-31.00
Cash Flow from Financing Activities
-526.00
-18.00
-18.00
0.00
181.00
-74.00
Net Cash Inflow / Outflow
187.00
30.00
137.00
-61.00
211.00
-56.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
1.00
0.00
0.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of BioMarin Pharmaceutical, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
541.763
-1179
1,720.00
145.95%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-216.396
-483
267.00
55.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
572.841
837
-265.00
-31.56%
Cash Flow from Investing Activities
136.491
-178
314.00
176.68%
Cash Flow from Financing Activities
-526.447
-570
44.00
7.64%
Net Cash Inflow / Outflow
187.715
79
108.00
137.61%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.83
-10
14.00
148.30%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 259.69% vs -9.46% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
572.84
159.26
259.69%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
